
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **CPA3, TPSAB1, TPSB2, MS4A2, HPGDS, HDC, LTC4S, ALOX5AP, ALOX5**: These genes are associated with mast cell function. CPA3 (Carboxypeptidase A3), TPSAB1, and TPSB2 (Tryptase alpha/beta 1 and 2) are enzymes involved in the degradation of proteins and are highly specific to mast cells. MS4A2 (also known as FcŒµRIŒ≤) is part of the high-affinity IgE receptor complex, crucial for allergic responses. HPGDS (Hematopoietic prostaglandin D synthase) and HDC (Histidine decarboxylase) are involved in prostaglandin and histamine synthesis, respectively, both of which are key mediators in mast cell activity. LTC4S (Leukotriene C4 synthase) and ALOX5/ALOX5AP are involved in leukotriene synthesis, important in inflammatory responses.<br>- **KIT**: A receptor tyrosine kinase essential for mast cell development and function.<br>- **FCER1A, FCER1G**: Components of the high-affinity IgE receptor, critical for mast cell activation.<br>- **IL1RL1 (ST2)**: A receptor involved in the immune response, often expressed in mast cells.<br>- **RGS13, RGS1, RGS2**: Regulators of G-protein signaling, involved in modulating mast cell responses.<br><br>### Step 2: List the Key Cell Type Markers<br>- **CPA3, TPSAB1, TPSB2, MS4A2, KIT, FCER1A, FCER1G**: These markers are highly specific to mast cells, indicating their presence and activity.<br>- **HPGDS, HDC, LTC4S, ALOX5AP, ALOX5**: These are also indicative of mast cells due to their roles in synthesizing mediators like histamine and leukotrienes.<br><br>### Step 3: Cross-reference Known Databases<br>- **Mast Cell Markers**: The Human Protein Atlas and other scRNA-seq databases consistently list CPA3, TPSAB1, TPSB2, MS4A2, and KIT as definitive markers for mast cells. The presence of these markers in high expression strongly suggests a mast cell identity.<br>- **Literature**: Numerous studies on mast cells in various tissues, including cancerous tissues, confirm the expression of these markers as characteristic of mast cells.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of the markers CPA3, TPSAB1, TPSB2, MS4A2, KIT, and others, the most probable general cell type is **Mast Cells**. These markers are highly specific and indicative of mast cell identity.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>Mast cells are generally not subdivided into many subtypes based on current knowledge, but variations can occur based on tissue localization and functional state. However, within the context of breast cancer tissue, we can consider:<br>1. **Connective Tissue Mast Cells**: Typically found in connective tissues, characterized by the expression of tryptase and chymase.<br>2. **Mucosal Mast Cells**: Found in mucosal tissues, often expressing tryptase but not chymase.<br>3. **Tumor-associated Mast Cells**: These may exhibit altered expression profiles due to the tumor microenvironment, potentially showing differential expression of cytokines and receptors.<br><br>Given the dataset is from breast cancer tissue, the most likely subtype is **Tumor-associated Mast Cells**, as they may play roles in tumor progression and immune modulation.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset strongly indicates that the cell cluster is composed of mast cells. The expression of key markers such as CPA3, TPSAB1, TPSB2, MS4A2, and KIT, which are definitive for mast cells, supports this conclusion. Within the context of breast cancer, these are most likely tumor-associated mast cells, which may have unique roles in the tumor microenvironment.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result for the cell cluster as mast cells is consistent with the provided marker list and the known characteristics of mast cells. Here's the breakdown of the validation:<br><br>1. **Marker Consistency**: <br>   - The key functional markers identified in the annotation (CPA3, TPSAB1, TPSB2, MS4A2, KIT, etc.) are present in the provided marker list. These markers are well-established indicators of mast cells.<br>   - The additional markers such as HPGDS, HDC, LTC4S, ALOX5AP, and ALOX5 further support the mast cell identity due to their roles in synthesizing mediators like histamine and leukotrienes, which are characteristic of mast cell function.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation does not suggest the presence of multiple distinct cell types within the cluster. The markers listed are highly specific to mast cells, and there is no strong evidence from the marker list to suggest a mixed cell population.<br>   - The annotation appropriately considers the possibility of tumor-associated mast cells, which is relevant given the breast cancer tissue context.<br><br>Overall, the annotation is well-supported by the marker list and aligns with known databases and literature on mast cell markers. The identification of the cell cluster as mast cells, particularly tumor-associated mast cells in the context of breast cancer tissue, is appropriate and justified.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Mast Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Connective Tissue Mast Cells</li><li>Mucosal Mast Cells</li><li>Tumor-associated Mast Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided for the single-cell dataset derived from breast cancer tissue are generally well-executed, with a strong focus on identifying mast cells as the primary cell type. The analysis effectively highlights key markers such as CPA3, TPSAB1, TPSB2, MS4A2, and KIT, which are well-established indicators of mast cells. This is a significant strength, as these markers are indeed highly specific to mast cells and are crucial for their identification.<br><br>The annotation process demonstrates a balanced consideration of multiple markers, not overly focusing on a single one. The inclusion of additional markers like HPGDS, HDC, LTC4S, ALOX5AP, and ALOX5, which are involved in synthesizing mediators characteristic of mast cell function, further supports the mast cell identity. This comprehensive approach ensures that the annotation captures the general picture of the cell population.<br><br>The analysis also appropriately considers the context of breast cancer tissue, suggesting the presence of tumor-associated mast cells. This consideration is crucial, as the tumor microenvironment can influence the expression profiles of cells, and tumor-associated mast cells may exhibit unique roles in cancer progression and immune modulation.<br><br>However, there are a few areas where the annotation could be improved. While the annotation does not suggest the presence of multiple distinct cell types within the cluster, it could have explored the possibility of mixed cell populations more thoroughly, given the complexity of tumor microenvironments. Additionally, while the rank of the markers is considered, the analysis could have emphasized the importance of the order in which markers appear, as those listed first may carry more weight in determining cell identity.<br><br>Overall, the annotation is scientifically accurate, well-balanced in its use of different markers, and provides a comprehensive view of the cell types present. There are no obvious misclassifications or oversights, and the analysis aligns well with known databases and literature on mast cell markers.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    